Rational Design and Synthesis of Highly Potent β‐Glucocerebrosidase Inhibitors

This publication has 18 references indexed in Scilit:

• N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
• A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity
  Trends in Pharmacological Sciences, 2003
• Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins
  Biochemical Journal, 2002
• The synthesis of a carbohydrate-like dihydrooxazine and tetrahydrooxazine as putative inhibitors of glycoside hydrolases: A direct synthesis of isofagomine
  Canadian Journal of Chemistry, 2002
• In vitro inhibition and intracellular enhancement of lysosomal α‐galactosidase A activity in Fabry lymphoblasts by 1‐deoxygalactonojirimycin and its derivatives
  European Journal of Biochemistry, 2000
• Chemical modification of β-glucocerebrosidase inhibitor N -octyl-β-valienamine: synthesis and biological evaluation of N -alkanoyl and N -alkyl derivatives
  Bioorganic & Medicinal Chemistry, 1998
• 1-N-Iminosugars: Potent and Selective Inhibitors of β-Glycosidases
  Journal of the American Chemical Society, 1998
• Structures and mechanisms of glycosyl hydrolases
  Structure, 1995
• Isofagomine, a Potent, New Glycosidase Inhibitor
  Angewandte Chemie International Edition in English, 1994
• Isofagomin, ein wirksamer neuer Glycosidaseinhibitor
  Angewandte Chemie, 1994